The opsin-based (and other gene therapy) treatment requires evaluation of potency in-vitro (for release characterization of drug) and objective clinical ...
https://www.google.com/url?rct=j&sa=t&url=https://www.prnewswire.com/news-releases/nanoscope-team-conferred-phase-ii-retinal-organoid-challenge-roc-award-by-national-institute-of-health-301220526.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEjul2UbaX0Bu3QVT1sY5gY8DcqjQ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.